2013•Leukemia ResearchRequires access

P-310 Eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: Results of a prospective, randomized trial

Esther N. Oliva, Valeria Santini, Gina Zini, Giuseppe A. Palumbo, Antonella Poloni, Agostino Cortelezzi, Francesco Rodeghiero, Maria Teresa Voso, Alfredo Molteni, Grazia Sanpaolo, Milanese C. Liberati, Francesco Carlo Morabito, Enrico Balleari, Stefana Impera, Flavia Salvi, Maria Antonietta Aloe Spiriti, Achille Marino, Filippo Rodà, C. Alati, Francesca Ronco, Francesco Di Raimondo, Pietro Leoni, G. Alimena, Roberto Latagliata, Francesco Nobile

Open publisher page 6 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Eltrombopag, Myelodysplastic syndromes, Medicine, International Prognostic Scoring System, Randomized controlled trial, Internal medicine, Gastroenterology, Immune thrombocytopenia